Citations (174)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (174)
Yuejing Wang, Zhuo Chen, Jing Wu, Hong Yan, Yiran Wang & Jie He. (2024) The Mutation and Low Expression of ARID1A are Predictive of a Poor
Prognosis and High Immune Infiltration in Triple-negative Breast Cancer. Current Cancer Drug Targets 24:1, pages 59-68.
Crossref
Crossref
Xuemei Zhang, Youzhi Zhang, Qiaoyun Zhang, Mengyao Lu, Yuan Chen, Xiaoyu Zhang & Peng Zhang. (2023) Role of AT‐rich interaction domain 1A in gastric cancer immunotherapy: Preclinical and clinical perspectives. Journal of Cellular and Molecular Medicine.
Crossref
Crossref
Baoling Xing, Xiaoying Zhang, Xia Gu, Lintao Xiang, Cuiping Wang & Yueling Jin. (2023) Explore the alterations of downstream molecular pathways caused by ARID1A mutation/knockout in human endometrial cancer cells. Journal of Cancer Research and Clinical Oncology 149:19, pages 17529-17541.
Crossref
Crossref
Yang Li, Yang Liu, Keyan Yang, Ling Jin, Jing Yang, Shuang Huang, Ying Liu, Bo Hu, Rong Liu, Wei Liu, Ansheng Liu, Qinlong Zheng & Yonghong Zhang. (2023) Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy. Cancer Cell International 23:1.
Crossref
Crossref
Yifan Zhou, Kaixuan Luo, Lifan Liang, Mengjie Chen & Xin He. (2023) A new Bayesian factor analysis method improves detection of genes and biological processes affected by perturbations in single-cell CRISPR screening. Nature Methods 20:11, pages 1693-1703.
Crossref
Crossref
Kavya V. Anilkumar, L.P. Rema, Mithun Chacko John, T. Vanesa John & Alex George. (2023) miRNAs in the prognosis of triple-negative breast cancer: A review. Life Sciences 333, pages 122183.
Crossref
Crossref
Roisin E. O'Cearbhaill, Austin Miller, Robert A. Soslow, Heather A. Lankes, Deborah DeLair, Sheila Segura, Shweta Chavan, Dmitriy Zamarin, Robert DeBernardo, Kathleen Moore, John Moroney, Mark Shahin, Premal H. Thaker, Andrea E. Wahner-Hendrickson & Carol Aghajanian. (2023) A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283. Gynecologic Oncology 176, pages 16-24.
Crossref
Crossref
Tatiana S. Driva, Christoph Schatz & Johannes Haybaeck. (2023) Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis. Biomolecules 13:8, pages 1253.
Crossref
Crossref
Zheng-Cheng Yu, Tianhe Li, Ellen Tully, Peng Huang, Chih-Ning Chen, Philipp Oberdoerffer, Stephanie Gaillard, Ie-Ming Shih & Tian-Li Wang. (2023)
Temozolomide Sensitizes
ARID1A
-Mutated Cancers to PARP Inhibitors
. Cancer Research 83:16, pages 2750-2762.
Crossref
Crossref
Cornelis J. Boogerd, Ilaria Perini, Eirini Kyriakopoulou, Su Ji Han, Phit La, Britt van der Swaan, Jari B. Berkhout, Danielle Versteeg, Jantine Monshouwer-Kloots & Eva van Rooij. (2023) Cardiomyocyte proliferation is suppressed by ARID1A-mediated YAP inhibition during cardiac maturation. Nature Communications 14:1.
Crossref
Crossref
Zhenkun Zhang, Qiujing Li, Shanshan Sun, Jing Ye, Zhe Li, Zhengguo Cui, Qian Liu, Yujie Zhang, Sili Xiong & Shukun Zhang. (2023)
Prognostic and immune infiltration significance of
ARID1A
in
TCGA
molecular subtypes of gastric adenocarcinoma
. Cancer Medicine 12:16, pages 16716-16733.
Crossref
Crossref
Qingjiang Hu, Eiji Oki, Teppei Yamada, Tomomi Kashiwada, Hideto Sonoda, Masato Kataoka, Hirofumi Kawanaka, Yasushi Tsuji, Akitaka Makiyama, Yuichiro Nakashima, Mitsuhiko Ota, Yasue Kimura & Tomoharu Yoshizumi. (2023)
Genomic characterization between
HER2
‐positive and negative gastric cancer patients in a prospective trial
. Cancer Medicine 12:15, pages 16649-16660.
Crossref
Crossref
Dantong Sun, Han Zhao, Hai Zhou, Junyan Tao, Tianjun Li, Jingjuan Zhu & Helei Hou. (2023) ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma. Translational Oncology 33, pages 101685.
Crossref
Crossref
Liyuan Wang & Jinglong Tang. (2023) SWI/SNF complexes and cancers. Gene 870, pages 147420.
Crossref
Crossref
Yang-kai Jiang, Yu-jun Shuai, Hua-min Ding, Hui Zhang, Chao Huang, Liang Wang, Jia-yin Sun, Wen-jie Wei, Xing-yuan Xiao & Guo-song Jiang. (2023) ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer. Current Medical Science 43:3, pages 560-571.
Crossref
Crossref
Xuewei Zhang, Yixuan Zhang, Jinyi Zhao, Yinjie Wu, Na Zhang & Wenjing Shen. (2023)
ARID1A
mutations in cancer development: mechanism and therapy
. Carcinogenesis 44:3, pages 197-208.
Crossref
Crossref
Motoki Ono, Tsutomu Miyamoto, Ryoichi Asaka, Junko Uchikawa, Hirofumi Ando, Yasuhiro Tanaka, Manaka Shinagawa, Yusuke Yokokawa, Shiho Asaka, Tian-Li Wang, Ie-Ming Shih & Tanri Shiozawa. (2023) Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout mice. Scientific Reports 13:1.
Crossref
Crossref
Fukang Jin, Zhiguang Yang, Jingbo Shao, Jianxin Tao, Christoph Reißfelder, Sonja Loges, Lei Zhu & Sebastian Schölch. (2023) ARID1A mutations in lung cancer: biology, prognostic role, and therapeutic implications. Trends in Molecular Medicine.
Crossref
Crossref
Danielle D. Dang, Jared S. Rosenblum, Ashish H. Shah, Zhengping Zhuang & Tara T. Doucet-O’Hare. (2023) Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications. Cancers 15:9, pages 2511.
Crossref
Crossref
Ahmed S. Doghish, Mohamed A. Ali, Salah S. Elyan, Mahmoud A. Elrebehy, Hend H. Mohamed, Reda M. Mansour, Ayatallah Elgohary, Aml Ghanem, Ahmed H.I. Faraag, Nourhan M. Abdelmaksoud & Hebatallah Ahmed Mohamed Moustafa. (2023) miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay. Pathology - Research and Practice 244, pages 154386.
Crossref
Crossref
Guang-Xiao Meng, Chun-Cheng Yang, Lun-Jie Yan, Ya-Fei Yang, Yu-Chuan Yan, Jian-Guo Hong, Zhi-Qiang Chen, Zhao-Ru Dong & Tao Li. (2023) The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma. Heliyon 9:3, pages e14307.
Crossref
Crossref
Shiho Asaka, Ying Liu, Zheng-Cheng Yu, Yohan Suryo Rahmanto, Motoki Ono, Ryoichi Asaka, Tsutomu Miyamoto, Ting-Tai Yen, Ayse Ayhan, Tian-Li Wang & Ie-Ming Shih. (2023) ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis. Modern Pathology 36:2, pages 100045.
Crossref
Crossref
Luisana Molina Pimienta, Juan Carmilo Salgado Sánchez & Ingrid Hernández Cuello. (2023) Implicaciones en el tratamiento de pacientes con cáncer de mama y alteraciones en ARID1A. Universitas Médica 64:1.
Crossref
Crossref
Meng-Chao Chen, Hsuan-Yu Su, Yen-Hao Su, Kuo-Hung Huang, Wen-Liang Fang, Chii-Wann Lin, Ming-Huang Chen, Yee Chao, Su-Shun Lo, Anna Fen-Yau Li & Chew-Wun Wu. (2022) The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery. Journal of the Chinese Medical Association 86:1, pages 57-64.
Crossref
Crossref
María J. López, Junior Carbajal, Alejandro L. Alfaro, Luis G. Saravia, Daniel Zanabria, Jhajaira M. Araujo, Lidia Quispe, Alejandra Zevallos, José L. Buleje, Cristina Eunbee Cho, Marisol Sarmiento, Joseph A. Pinto & Williams Fajardo. (2023) Characteristics of gastric cancer around the world. Critical Reviews in Oncology/Hematology 181, pages 103841.
Crossref
Crossref
Wenjuan Xu, Haiying Dong, Guoqing Ru & Ming Zhao. (2022) ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications. Diagnostic Pathology 17:1.
Crossref
Crossref
Pallavi Shukla, Prerana Dange, Bhabani Shankar Mohanty, Nikhil Gadewal, Pradip Chaudhari & Rajiv Sarin. (2022) ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications. Cancer Gene Therapy 29:12, pages 1908-1917.
Crossref
Crossref
Zhicheng Wu, Qiu Wang, Xiuqing Liu, Jiantong Zheng, Ling Ji & Xiaofeng Li. (2022) Identification and Validation of a Novel Multiomics Signature for Prognosis and Immunotherapy Response of Endometrial Carcinoma. Journal of Oncology 2022, pages 1-13.
Crossref
Crossref
Jake J. Reske, Mike R. Wilson, Brooke Armistead, Shannon Harkins, Cristina Perez, Joel Hrit, Marie Adams, Scott B. Rothbart, Stacey A. Missmer, Asgerally T. Fazleabas & Ronald L. Chandler. (2022) ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers. BMC Biology 20:1.
Crossref
Crossref
Jayaprakash Mandal, Prativa Mandal, Tian-Li Wang & Ie-Ming Shih. (2022) Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response. Journal of Biomedical Science 29:1.
Crossref
Crossref
Burcu Akman & Serap Erkek-Ozhan. 2022. Urologic Cancers. Urologic Cancers
45
60
.
Nithya Krishnamurthy, Shumei Kato, Scott Lippman & Razelle Kurzrock. (2022) Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy. Journal for ImmunoTherapy of Cancer 10:9, pages e004669.
Crossref
Crossref
Lena Hess, Verena Moos, Arnel A. Lauber, Wolfgang Reiter, Michael Schuster, Natascha Hartl, Daniel Lackner, Thorina Boenke, Anna Koren, Paloma M. Guzzardo, Brigitte Gundacker, Anna Riegler, Petra Vician, Claudia Miccolo, Susanna Leiter, Mahesh B. Chandrasekharan, Terezia Vcelkova, Andrea Tanzer, Jun Qi Jun, James Bradner, Gerald Brosch, Markus Hartl, Christoph Bock, Tilmann Bürckstümmer, Stefan Kubicek, Susanna Chiocca, Srividya Bhaskara & Christian Seiser. (2022) A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation. PLOS Genetics 18:8, pages e1010376.
Crossref
Crossref
Jaime Iranzo, George Gruenhagen, Jorge Calle-Espinosa & Eugene V. Koonin. (2022) Pervasive conditional selection of driver mutations and modular epistasis networks in cancer. Cell Reports 40:8, pages 111272.
Crossref
Crossref
Zhiwei Cui, Jiantao Mo, Lijun Wang, Rongli Wang, Feiyan Cheng, Lihui Wang, Xinyuan Yang & Wei Wang. (2022) Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer. Frontiers in Genetics 13.
Crossref
Crossref
Ulrike Pfohl, Jürgen Loskutov, Sanum Bashir, Ralf Kühn, Patrick Herter, Markus Templin, Soulafa Mamlouk, Sergei Belanov, Michael Linnebacher, Florian Bürtin, Marcus Vetter, Christoph Reinhard, Lena Wedeken & Christian R. A. Regenbrecht. (2022) A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer. Cancers 14:13, pages 3252.
Crossref
Crossref
Xuan Wang, Keying Che, Tao Shi, Qin Liu, Xinyun Xu, Hongyan Wu, Lixia Yu, Baorui Liu & Jia Wei. (2022) Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer. Journal of Cancer Research and Clinical Oncology 148:7, pages 1583-1595.
Crossref
Crossref
Cristina Megino‐Luque, Pol Sisó, Natalia Mota‐Martorell, Raúl Navaridas, Inés de la Rosa, Izaskun Urdanibia, Manel Albertí‐Valls, Maria Santacana, Miquel Pinyol, Núria Bonifaci, Anna Macià, David Llobet‐Navas, Sònia Gatius, Xavier Matias‐Guiu & Núria Eritja. (2022)
ARID1A
‐deficient cells require HDAC6 for progression of endometrial carcinoma
. Molecular Oncology 16:11, pages 2235-2259.
Crossref
Crossref
Jooske L. Monster, Lars J.S. Kemp, Martijn Gloerich & Rachel S. van der Post. (2022) Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:3, pages 188719.
Crossref
Crossref
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, Jan-Malte Placke, Eleftheria Chorti, Anne Zaremba, Georg Lodde, Philipp Jansen, Frederik Krefting, Julia Kretz, Inga Möller, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Lisa Zimmer, Selma Ugurel, Dirk Schadendorf, Eva Hadaschik & Klaus G. Griewank. (2022) Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival. Cancers 14:9, pages 2090.
Crossref
Crossref
Xu Zhang, Yuxiang Wang & Linghua Meng. (2022) Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy. Acta Pharmaceutica Sinica B 12:3, pages 1054-1067.
Crossref
Crossref
Hyunsung Kim & Young Hyeh Ko. (2022) The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma. Life 12:1, pages 73.
Crossref
Crossref
Jayson J. Smith, Yutong Xiao, Nithin Parsan, Taylor N. Medwig-Kinney, Michael A. Q. Martinez, Frances E. Q. Moore, Nicholas J. Palmisano, Abraham Q. Kohrman, Mana Chandhok Delos Reyes, Rebecca C. Adikes, Simeiyun Liu, Sydney A. Bracht, Wan Zhang, Kailong Wen, Paschalis Kratsios & David Q. Matus. (2022) The SWI/SNF chromatin remodeling assemblies BAF and PBAF differentially regulate cell cycle exit and cellular invasion in vivo. PLOS Genetics 18:1, pages e1009981.
Crossref
Crossref
Antonio Simone Laganà & Antoine Naem. 2022. Stem Cells in Reproductive Tissues and Organs. Stem Cells in Reproductive Tissues and Organs
193
216
.
Christian A. Lee, Diala Abd-Rabbo & Jüri Reimand. (2021) Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes. Genome Biology 22:1.
Crossref
Crossref
Qianfu Zhao, Qu Cai, Shanhe Yu, Jun Ji, Zhenggang Zhu, Chao Yan & Jun Zhang. (2021) Combinatorial Analysis of AT-Rich Interaction Domain 1A and CD47 in Gastric Cancer Patients Reveals Markers of Prognosis. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Yue Li, Shao-yan Xi, Juan-juan Yong, Xiao-yan Wu, Xin-hua Yang & Fang Wang. (2021) Morphologic, Immunohistochemical, and Genetic Differences Between High-grade and Low-grade Fetal Adenocarcinomas of the Lung. American Journal of Surgical Pathology 45:11, pages 1464-1475.
Crossref
Crossref
Corey M. Gill, Joshua Loewenstern, John W. Rutland, Hanane Arib, Margaret Pain, Melissa Umphlett, Yayoi Kinoshita, Russell B. McBride, Joshua Bederson, Michael Donovan, Robert Sebra, Mary Fowkes & Raj K. Shrivastava. (2021) SWI/SNF chromatin remodeling complex alterations in meningioma. Journal of Cancer Research and Clinical Oncology 147:11, pages 3431-3440.
Crossref
Crossref
Shouying Xu & Chao Tang. (2021) The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?. Frontiers in Oncology 11.
Crossref
Crossref
Yao Xiao, Guodong Liu, Xiwu Ouyang, Denggao Zai, Jixiang Zhou, Xiaoli Li, Qi Zhang & Jie Zhao. (2021) Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Crossref
Adrian Kwan Ho Loe, Roshane Francis, Jieun Seo, Lutao Du, Yunshan Wang, Ji-Eun Kim, Shaheed W. Hakim, Jung-Eun Kim, Housheng Hansen He, Haiyang Guo & Tae-Hee Kim. (2021)
Uncovering the dosage-dependent roles of
Arid1a
in gastric tumorigenesis for combinatorial drug therapy
. Journal of Experimental Medicine 218:6.
Crossref
Crossref
Olena Odnokoz, Cindy Wavelet-Vermuse, Shelby L Hophan, Serdar Bulun & Yong Wan. (2021) ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics. Epigenomics 13:10, pages 809-823.
Crossref
Crossref
Long Wang, Yi-Meng Jia, Jing Zuo, Yu-Dong Wang, Zhi-Song Fan, Li Feng, Xue Zhang, Jing Han, Wen-Jing Lyu & Zhi-Yu Ni. (2021) Gene mutations of esophageal squamous cell carcinoma based on next-generation sequencing. Chinese Medical Journal 134:6, pages 708-715.
Crossref
Crossref
Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh M. Advani, Riham Katkhuda, Anuj Verma, Michael Lam, Jason Willis, John Paul Shen, Jeffrey Morris, Jennifer S. Davis, Jonathan M. Loree, Hey Min Lee, Jaffer A. Ajani, Dipen M. Maru, Michael J. Overman & Scott Kopetz. (2021) ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clinical Cancer Research 27:6, pages 1663-1670.
Crossref
Crossref
Luca Pagliaroli & Marco Trizzino. (2021) The Evolutionary Conserved SWI/SNF Subunits ARID1A and ARID1B Are Key Modulators of Pluripotency and Cell-Fate Determination. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Renáta Váraljai, Susanne Horn, Antje Sucker, Daniela Piercianek, Verena Schmitt, Alexander Carpinteiro, Katrin Anne Becker, Julia Reifenberger, Alexander Roesch, Jörg Felsberg, Guido Reifenberger, Ulrich Sure, Dirk Schadendorf & Iris Helfrich. (2021) Integrative Genomic Analyses of Patient-Matched Intracranial and Extracranial Metastases Reveal a Novel Brain-Specific Landscape of Genetic Variants in Driver Genes of Malignant Melanoma. Cancers 13:4, pages 731.
Crossref
Crossref
Hideo Tomihara, Federica Carbone, Luigi Perelli, Justin K. Huang, Melinda Soeung, Johnathon L. Rose, Frederick S. Robinson, Yonathan Lissanu Deribe, Ningping Feng, Mitsunobu Takeda, Akira Inoue, Edoardo Del Poggetto, Angela K. Deem, Anirban Maitra, Pavlos Msaouel, Nizar M. Tannir, Giulio F. Draetta, Andrea Viale, Timothy P. Heffernan, Christopher A. Bristow, Alessandro Carugo & Giannicola Genovese. (2021) Loss of ARID1A Promotes Epithelial–Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress. Cancer Research 81:2, pages 332-343.
Crossref
Crossref
Un Suk Jung, Kyueng-Whan Min, Dong-Hoon Kim, Mi Jung Kwon, HoHyun Park & Hyung Seok Jang. (2021) Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma. Journal of Gynecologic Oncology 32:1.
Crossref
Crossref
Giuseppe Tonini, Michele Iuliani, Giulia Ribelli, Sonia Simonetti & Francesco Pantano. 2021. Practical Medical Oncology Textbook. Practical Medical Oncology Textbook
675
688
.
Yueming Zhang, Anqi Lin, Yonghe Li, Weimin Ding, Hui Meng, Peng Luo & Jian Zhang. (2020) Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Simon Schallenberg, Julian Bork, Ahlem Essakly, Hakan Alakus, Reinhard Buettner, Axel M. Hillmer, Christiane Bruns, Wolfgang Schroeder, Thomas Zander, Heike Loeser, Florian Gebauer & Alexander Quaas. (2020) Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma. BMC Cancer 20:1.
Crossref
Crossref
Si-Hyong Jang, Ji-Hye Lee, Hyun Ju Lee, Hyundeuk Cho, Hyein Ahn, In Hag Song & Mee-Hye Oh. (2020) Loss of ARID1A expression is associated with poor prognosis in non-small cell lung cancer. Pathology - Research and Practice 216:11, pages 153156.
Crossref
Crossref
Mike R. Wilson, Jake J. Reske, Jeanne Holladay, Subechhya Neupane, Julie Ngo, Nina Cuthrell, Marc Wegener, Mary Rhodes, Marie Adams, Rachael Sheridan, Galen Hostetter, Fahad T. Alotaibi, Paul J. Yong, Michael S. Anglesio, Bruce A. Lessey, Richard E. Leach, Jose M. Teixeira, Stacey A. Missmer, Asgerally T. Fazleabas & Ronald L. Chandler. (2020) ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation. Cell Reports 33:6, pages 108366.
Crossref
Crossref
Qingyu Luo, Xiaowei Wu & Zhihua Liu. (2020) Remodeling of the ARID1A tumor suppressor. Cancer Letters 491, pages 1-10.
Crossref
Crossref
Li Wang, Jialin Qu, Na Zhou, Helei Hou, Man Jiang & Xiaochun Zhang. (2020) Effect and biomarker of immune checkpoint blockade therapy for ARID1A deficiency cancers. Biomedicine & Pharmacotherapy 130, pages 110626.
Crossref
Crossref
Jasiya Qadir, Sabhiya Majid, Mosin S. Khan, Fouzia Rashid, Mumtaz Din Wani, Inshah Din & Haamid Bashir. (2020) AT-rich Interaction Domain 1A Gene Variations: Genetic Associations and Susceptibility to Gastric Cancer Risk. Pathology & Oncology Research 26:4, pages 2237-2246.
Crossref
Crossref
Yu-Chan Chang, Ming-Huang Chen, Chun-Nan Yeh & Michael Hsiao. (2020) Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma. Biomolecules 10:10, pages 1377.
Crossref
Crossref
Kuo-Hung Huang, Ming-Huang Chen, Wen-Liang Fang, Chien-Hsing Lin, Yee Chao, Su-Shun Lo, Anna Fen-Yau Li, Chew-Wun Wu & Yi-Ming Shyr. (2020) The Clinicopathological Characteristics And Genetic Alterations of Signet-ring Cell Carcinoma in Gastric Cancer. Cancers 12:8, pages 2318.
Crossref
Crossref
Liudmila M. Mikhaleva, Aleksandr I. Davydov, Olga I. Patsap, Elizaveta V. Mikhaylenko, Vladimir N. Nikolenko, Margarita E. Neganova, Sergey G. Klochkov, Siva G. Somasundaram, Cecil E. Kirkland & Gjumrakch Aliev. (2020) Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review. Advances in Therapy 37:6, pages 2580-2603.
Crossref
Crossref
Guangyuan Hu, Wei Tu, Liu Yang, Guang Peng & Lin Yang. (2020) ARID1A deficiency and immune checkpoint blockade therapy: From mechanisms to clinical application. Cancer Letters 473, pages 148-155.
Crossref
Crossref
Mohammad‐Nazir Menbari, Karim Rahimi, Abbas Ahmadi, Samira Mohammadi‐Yeganeh, Anvar Elyasi, Nikoo Darvishi, Vahedeh Hosseini & Mohammad Abdi. (2019)
miR‐483‐3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the
HDAC8
>oncogene
. Journal of Cellular Physiology 235:3, pages 2631-2642.
Crossref
Crossref
Evangelia Pavlidou & Vasileios Balis. (2020) Diagnostic significance and prognostic role of the ARID1A gene in cancer outcomes (Review). World Academy of Sciences Journal.
Crossref
Crossref
Yeh WangKristen NicholesIe-Ming Shih. (2020) The Origin and Pathogenesis of Endometriosis. Annual Review of Pathology: Mechanisms of Disease 15:1, pages 71-95.
Crossref
Crossref
Malyasree Giri, Aditi Maulik & Mahavir Singh. (2019) Signatures of Specific DNA Binding by the AT-Rich Interaction Domain of BAF250a. Biochemistry 59:1, pages 100-113.
Crossref
Crossref
Chia-Hung Wu, Chien-Hsun Tseng, Kuo-Hung Huang, Wen-Liang Fang, Ming-Huang Chen, Anna F Li & Chew-Wun Wu. (2020) The clinical signiicance of ARID1A mutations in gastric cancer patients. Formosan Journal of Surgery 53:3, pages 93-100.
Crossref
Crossref
Hossein Taghizadeh, Leonhard Müllauer, Robert M. Mader, Martin Schindl & Gerald W. Prager. (2020) Applied precision medicine in metastatic pancreatic ductal adenocarcinoma. Therapeutic Advances in Medical Oncology 12, pages 175883592093861.
Crossref
Crossref
Ting-Tai Yen, Tian-Li Wang, Amanda N. Fader, Ie-Ming Shih & Stéphanie Gaillard. (2020) Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer. International Journal of Gynecological Pathology 39:1, pages 26-35.
Crossref
Crossref
Yuanyuan Sun, Nan Miao & Tao Sun. (2019) Detect accessible chromatin using ATAC-sequencing, from principle to applications. Hereditas 156:1.
Crossref
Crossref
Takahiko Koyama, Kahn Rhrissorrakrai & Laxmi Parida. (2019) Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients. BMC Cancer 19:1.
Crossref
Crossref
Takahiro Kodama, Teresa A. MarianHubert LeeMichiko KodamaJian LiMichael S. ParmacekNancy A. Jenkins, Neal G. Copeland & Zhubo Wei. (2019) MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM. Proceedings of the National Academy of Sciences 116:47, pages 23625-23635.
Crossref
Crossref
Pradip De & Nandini Dey. (2019) Mutation-Driven Signals of ARID1A and PI3K Pathways in Ovarian Carcinomas: Alteration Is An Opportunity. International Journal of Molecular Sciences 20:22, pages 5732.
Crossref
Crossref
Keerakarn Somsuan, Paleerath Peerapen, Wanida Boonmark, ikanya Plumworasawat, Ratirath Samol, Natthiya Sakulsak & Visith Thongboonkerd. (2019)
ARID1A
knockdown triggers epithelial‐mesenchymal transition and carcinogenesis features of renal cells: role in renal cell carcinoma
. The FASEB Journal 33:11, pages 12226-12239.
Crossref
Crossref
Aditi Maulik, Malyasree Giri & Mahavir Singh. (2019)
Molecular determinants of complex formation between
DNA
and the
AT
‐rich interaction domain of
BAF
250a
. FEBS Letters 593:19, pages 2716-2729.
Crossref
Crossref
Youngran Park, M. Herman Chui, Yohan Suryo Rahmanto, Zheng-Cheng Yu, Raghavendra A. Shamanna, Marina A. Bellani, Stephanie Gaillard, Ayse Ayhan, Akila Viswanathan, Michael M. Seidman, Sonia Franco, Anthony K.L. Leung, Vilhelm A. Bohr, Ie-Ming Shih & Tian-Li Wang. (2019) Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy. Clinical Cancer Research 25:18, pages 5584-5594.
Crossref
Crossref
Yoshihiro Kishida, Takuma Oishi, Takashi Sugino, Akio Shiomi, Kenichi Urakami, Masatoshi Kusuhara, Ken Yamaguchi, Yuko Kitagawa & Hiroyuki Ono. (2019) Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer. American Journal of Clinical Pathology 152:4, pages 463-470.
Crossref
Crossref
Michaela Reagan. 2019. Cancer. Cancer
53
74
.
Weng, Lin & Cheng. (2019) The Use of Genetically Engineered Mouse Models for Studying the Function of Mutated Driver Genes in Pancreatic Cancer. Journal of Clinical Medicine 8:9, pages 1369.
Crossref
Crossref
Antonio Raffone, Antonio Travaglino, Gabriele Saccone, Miriam Cieri, Massimo Mascolo, Antonio Mollo, Luigi Insabato & Fulvio Zullo. (2019) Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer. APMIS 127:9, pages 597-606.
Crossref
Crossref
Lin Han, Vikas Madan, Anand Mayakonda, Pushkar Dakle, Teoh Weoi Woon, Pavithra Shyamsunder, Hazimah Binte Mohd Nordin, Zeya Cao, Janani Sundaresan, Ienglam Lei, Zhong Wang & H. Phillip Koeffler. (2019) Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice. Leukemia 33:9, pages 2291-2305.
Crossref
Crossref
Bastiaan G. Wortman, Remi A. Nout, Tjalling Bosse & Carien L. Creutzberg. (2019) Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors. Current Oncology Reports 21:9.
Crossref
Crossref
Sarah G. Dugas, David C. Müller, Clémentine Le Magnen, Joel Federer‐Gsponer, Hans‐Helge Seifert, Christian Ruiz, Spasenija Savic Prince, Tatjana Vlajnic, Tobias Zellweger, Kirsten D. Mertz, Jack V. W. Bacon, Alexander W. Wyatt, Cyrill A. Rentsch & Lukas Bubendorf. (2019) Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer. Cancer Cytopathology 127:9, pages 578-585.
Crossref
Crossref
Gong-Qing Shen, Essa M. Aleassa, R. Matthew Walsh & Gareth Morris-Stiff. (2019) Next-Generation Sequencing in Pancreatic Cancer. Pancreas 48:6, pages 739-748.
Crossref
Crossref
Venni Yuliantini, Wresnindyatsih, Aida Farida & Zen Hafy. (2019) ARID1A protein expression in endometriosis-associated ovarian carcinomas. Journal of Physics: Conference Series 1246:1, pages 012070.
Crossref
Crossref
Ning Xu, Lili Wang, Ping Sun, Suyang Xu, Shiping Fu & Zhihua Sun. (2017) Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma. Pathology & Oncology Research 25:3, pages 875-881.
Crossref
Crossref
Rafah A. A. Alnafakh, Meera Adishesh, Lucy Button, Gabriele Saretzki & Dharani K. Hapangama. (2019) Telomerase and Telomeres in Endometrial Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Hua Zhong & Mingzhou Song. (2019) A Fast Exact Functional Test for Directional Association and Cancer Biology Applications. IEEE/ACM Transactions on Computational Biology and Bioinformatics 16:3, pages 818-826.
Crossref
Crossref
Rama Rao Malla, Seema Kumari, Murali Mohan Gavara, Anil Kumar Badana, Shailender Gugalavath, Deepak Kakara Gift Kumar & Prasuja Rokkam. (2019) A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer. Biophysical Reviews 11:2, pages 227-234.
Crossref
Crossref
Jin-yan Wang & Li-juan Chen. (2019) The role of miRNAs in the invasion and metastasis of cervical cancer. Bioscience Reports 39:3.
Crossref
Crossref
Keyvan Torabi, Pau Erola, Maria Isabel Alvarez‐Mora, Marcos Díaz‐Gay, Queralt Ferrer, Antoni Castells, Sergi Castellví‐Bel, Montserrat Milà, Juan José Lozano, Rosa Miró, Thomas Ried, Immaculada Ponsa & Jordi Camps. (2018) Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers. International Journal of Cancer 144:3, pages 513-524.
Crossref
Crossref
Huan Zhou, Shun Tan, Hong Li & Xiangtao Lin. (2019) Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma. Molecular Medicine Reports.
Crossref
Crossref
Zhuandi Gong, Xiaoyun Shen, Juan Yang, Kun Yang, Shengju Bai & Suocheng Wei. (2019) FSH receptor binding inhibitor up-regulates ARID1A and PTEN genes associated with ovarian cancers in mice. Brazilian Journal of Medical and Biological Research 52:7.
Crossref
Crossref
Sumati Gupta, Daniel J. Albertson, Timothy J. Parnell, Andrew Butterfield, Alexis Weston, Lisa M. Pappas, Brian Dalley, John M. O’Shea, William T. Lowrance, Bradley R. Cairns, Joshua D. Schiffman & Sunil Sharma. (2019)
Histone Deacetylase Inhibition Has Targeted Clinical Benefit in
ARID1A
-Mutated Advanced Urothelial Carcinoma
. Molecular Cancer Therapeutics 18:1, pages 185-195.
Crossref
Crossref
Jeffrey D. Seidman, Brigitte M. Ronnett, Ie-Ming Shih, Kathleen R. Cho & Robert J. Kurman. 2019. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract
841
966
.
Jack Kuipers, Thomas Thurnherr, Giusi Moffa, Polina Suter, Jonas Behr, Ryan Goosen, Gerhard Christofori & Niko Beerenwinkel. (2018) Mutational interactions define novel cancer subgroups. Nature Communications 9:1.
Crossref
Crossref
Elena Fountzilas, Vassiliki Kotoula, Ioannis Tikas, Kyriaki Manousou, Kyriaki Papadopoulou, Christos Poulios, Vasilios Karavasilis, Ioannis Efstratiou, Dimitrios Pectasides, Kleo Papaparaskeva, Ioannis Varthalitis, Christos Christodoulou, George Papatsibas, Sofia Chrisafi, Georgios K. Glantzounis, Amanda Psyrri, Gerasimos Aravantinos, Georgia-Angeliki Koliou, George K. Koukoulis, George E. Pentheroudakis & George Fountzilas. (2018) Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer. Oncotarget 9:86, pages 35623-35638.
Crossref
Crossref
Lyla J Stanland & Micah A Luftig. (2018) Molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer. Future Virology 13:11, pages 803-818.
Crossref
Crossref
V. Pillonel, D. Juskevicius, C. K. Y. Ng, A. Bodmer, A. Zettl, D. Jucker, S. Dirnhofer & A. Tzankov. (2018) High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations. Leukemia 32:11, pages 2412-2426.
Crossref
Crossref
Nazar Mashtalir, Andrew R. D’Avino, Brittany C. Michel, Jie Luo, Joshua Pan, Jordan E. Otto, Hayley J. Zullow, Zachary M. McKenzie, Rachel L. Kubiak, Roodolph St. Pierre, Alfredo M. Valencia, Steven J. Poynter, Seth H. Cassel, Jeffrey A. Ranish & Cigall Kadoch. (2018) Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes. Cell 175:5, pages 1272-1288.e20.
Crossref
Crossref
Radhika Mathur. (2018) ARID1A loss in cancer: Towards a mechanistic understanding. Pharmacology & Therapeutics 190, pages 15-23.
Crossref
Crossref
Marion Magierowicz, Cécile Tomowiak, Xavier Leleu & Stéphanie Poulain. (2018) Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America 32:5, pages 753-763.
Crossref
Crossref
Qingyu Luo, Xiaowei Wu, Yiping Zhang, Tong Shu, Fang Ding, Hongyan Chen, Pengfei Zhao, Wan Chang, Xiaolin Zhu & Zhihua Liu. (2018) ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2. Cancer Letters 427, pages 9-17.
Crossref
Crossref
Martin Köbel, Michael S. Anglesio & James D. Brenton. (2018) You won't believe this old test … that does cheap single-cell mutation detection. The Journal of Pathology: Clinical Research 4:3, pages 149-153.
Crossref
Crossref
Saira Khalique, Kalnisha Naidoo, Ayoma D Attygalle, Divya Kriplani, Frances Daley, Anne Lowe, James Campbell, Thomas Jones, Michael Hubank, Kerry Fenwick, Nicholas Matthews, Alistair G Rust, Christopher J Lord, Susana Banerjee & Rachael Natrajan. (2018)
Optimised ARID1A immunohistochemistry is an accurate predictor of
ARID1A
mutational status in gynaecological cancers
. The Journal of Pathology: Clinical Research 4:3, pages 154-166.
Crossref
Crossref
Mihaela Chivu-Economescu, Lilia Matei, Laura G Necula, Denisa L Dragu, Coralia Bleotu & Carmen C Diaconu. (2018) New therapeutic options opened by the molecular classification of gastric cancer. World Journal of Gastroenterology 24:18, pages 1942-1961.
Crossref
Crossref
Jianfeng Shen, Zhenlin Ju, Wei Zhao, Lulu Wang, Yang Peng, Zhongqi Ge, Zachary D. Nagel, Jun Zou, Chen Wang, Prabodh Kapoor, Xiangyi Ma, Ding Ma, Jiyong Liang, Shumei Song, Jinsong Liu, Leona D. Samson, Jaffer A. Ajani, Guo-Min Li, Han Liang, Xuetong Shen, Gordon B. Mills & Guang Peng. (2018) ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade. Nature Medicine 24:5, pages 556-562.
Crossref
Crossref
Ji-Hye Choi, Young-Bae Kim, Ji Mi Ahn, Min Jae Kim, Won Jung Bae, Sang-Uk Han, Hyun Goo Woo & Dakeun Lee. (2018) Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer. Experimental & Molecular Medicine 50:4, pages 1-11.
Crossref
Crossref
F.E. Stubbs, M.T. Birnie, S.C. Biddie, S.L. Lightman & B.L. Conway-Campbell. (2018) SKOV3 cells containing a truncated ARID1a protein have a restricted genome-wide response to glucocorticoids. Molecular and Cellular Endocrinology 461, pages 226-235.
Crossref
Crossref
Stuart L. Cramer, Aubrey L. Miller, Joseph G. Pressey, Tracy L. Gamblin, Elizabeth A. Beierle, Brian D. Kulbersh, Patrick L. Garcia, Leona N. Council, Rupa Radhakrishnan, Skyler V. Hendrix, David R. Kelly, Raymond G. Watts & Karina J. Yoon. (2018) Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study. Frontiers in Oncology 7.
Crossref
Crossref
Jeffrey D. Seidman, Brigitte M. Ronnett, Ie-Ming Shih, Kathleen R. Cho & Robert J. Kurman. 2018. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract
1
128
.
Jeffrey D. Seidman, Brigitte M. Ronnett, Ie-Ming Shih, Kathleen R. Cho & Robert J. Kurman. 2018. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract
1
128
.
Wei Zhong Leong, Shi Hao Tan, Phuong Cao Thi Ngoc, Stella Amanda, Alice Wei Yee Yam, Wei-Siang Liau, Zhiyuan Gong, Lee N. Lawton, Daniel G. Tenen & Takaomi Sanda. (2017) ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. Genes & Development 31:23-24, pages 2343-2360.
Crossref
Crossref
Guangquan Liu, Pengfei Xu, Ziyi Fu, Xiangdong Hua, Xiaoguang Liu, Wenqu Li, Mi Zhang, Jiacong Wu, Juan Wen, Juan Xu & Xuemei Jia. (2017) Prognostic and Clinicopathological Significance of ARID1A in Endometrium‐Related Gynecological Cancers: A Meta‐Analysis. Journal of Cellular Biochemistry 118:12, pages 4517-4525.
Crossref
Crossref
Zhao-yun Li, Shan-shan Zhu, Xian-jun Chen, Jie Zhu, Qi Chen, Ya-qiong Zhang, Chun-ling Zhang, Ting-ting Guo & Li-ming Zhang. (2017) ARID1A suppresses malignant transformation of human pancreatic cells via mediating senescence-associated miR-503/CDKN2A regulatory axis. Biochemical and Biophysical Research Communications 493:2, pages 1018-1025.
Crossref
Crossref
Reiko Watanabe, Shin-ichiro Kanno, Amaneh Mohammadi Roushandeh, Ayako Ui & Akira Yasui. (2017) Nucleosome remodelling, DNA repair and transcriptional regulation build negative feedback loops in cancer and cellular ageing. Philosophical Transactions of the Royal Society B: Biological Sciences 372:1731, pages 20160473.
Crossref
Crossref
Ryusuke Murakami, Noriomi Matsumura, J.B. Brown, Koichiro Higasa, Takanobu Tsutsumi, Mayumi Kamada, Hisham Abou-Taleb, Yuko Hosoe, Sachiko Kitamura, Ken Yamaguchi, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masafumi Koshiyama, Yasushi Okuno, Ryo Yamada, Fumihiko Matsuda, Ikuo Konishi & Masaki Mandai. (2017) Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks. The American Journal of Pathology 187:10, pages 2246-2258.
Crossref
Crossref
Claudio Luchini, Scott A Robertson, Seung-Mo Hong, Matthäus Felsenstein, Robert A Anders, Antonio Pea, Alessia Nottegar, Nicola Veronese, Jin He, Matthew J Weiss, Paola Capelli, Aldo Scarpa, Pedram Argani, Payal Kapur & Laura D Wood. (2017) PBRM1 loss is a late event during the development of cholangiocarcinoma. Histopathology 71:3, pages 375-382.
Crossref
Crossref
Lihong Zhang, Jianfeng Shen, Yuping Yin, Yang Peng, Lulu Wang, Hui-Ju Hsieh, Qian Shen, Powel H. Brown, Kaixiong Tao, Ivan P. Uray & Guang Peng. (2017) Identifying Cell Cycle Modulators That Selectively Target ARID1A Deficiency Using High-Throughput Image-Based Screening. SLAS Discovery 22:7, pages 813-826.
Crossref
Crossref
Michael G. Drage, Mingkhwan Tippayawong, Agoston T. Agoston, Yifan Zheng, Raphael Bueno, Jason L. Hornick, Robert D. Odze & Amitabh Srivastava. (2017) Morphological Features and Prognostic Significance of ARID1A-Deficient Esophageal Adenocarcinomas. Archives of Pathology & Laboratory Medicine 141:7, pages 970-977.
Crossref
Crossref
Marie Bidart, Michèle El Atifi, Sarra Miladi, John Rendu, Véronique Satre, Pierre F. Ray, Caroline Bosson, Françoise Devillard, Daphné Lehalle, Valérie Malan, Jeanne Amiel, Maria Antonietta Mencarelli, Margherita Baldassarri, Alessandra Renieri, Jill Clayton-Smith, Gaëlle Vieville, Julien Thevenon, Florence Amblard, François Berger, Pierre-Simon Jouk & Charles Coutton. (2016) Microduplication of the ARID1A gene causes intellectual disability with recognizable syndromic features. Genetics in Medicine 19:6, pages 701-710.
Crossref
Crossref
Livia Ronchetti, Elisa Melucci, Francesca De Nicola, Frauke Goeman, Beatrice Casini, Francesca Sperati, Matteo Pallocca, Irene Terrenato, Laura Pizzuti, Patrizia Vici, Domenico Sergi, Luigi Di Lauro, Carla Azzurra Amoreo, Enzo Gallo, Maria Grazia Diodoro, Edoardo Pescarmona, Ilio Vitale, Maddalena Barba, Simonetta Buglioni, Marcella Mottolese, Maurizio Fanciulli, Ruggero De Maria & Marcello Maugeri-Saccà. (2017) DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy. International Journal of Cancer 140:11, pages 2587-2595.
Crossref
Crossref
J Li, Y Xi, W Li, R L McCarthy, S A Stratton, W Zou, W Li, S Y Dent, A K Jain & M C Barton. (2017) TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. Oncogene 36:21, pages 2991-3001.
Crossref
Crossref
Andrew D. Cherniack, Hui Shen, Vonn Walter, Chip Stewart, Bradley A. Murray, Reanne Bowlby, Xin Hu, Shiyun Ling, Robert A. Soslow, Russell R. Broaddus, Rosemary E. Zuna, Gordon Robertson, Peter W. Laird, Raju Kucherlapati, Gordon B. Mills, John N. Weinstein, Jiashan Zhang, Rehan Akbani, Douglas A. Levine, Rehan Akbani, Adrian Ally, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Stephen B. Baylin, Rameen Beroukhim, Tom Bodenheimer, Faina Bogomolniy, Lori Boice, Moiz S. Bootwalla, Jay Bowen, Reanne Bowlby, Russell Broaddus, Denise Brooks, Rebecca Carlsen, Andrew D. Cherniack, Juok Cho, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Melissa Cline, Fanny Dao, Mutch David, John A. Demchok, Noreen Dhalla, Sean Dowdy, Ina Felau, Martin L. Ferguson, Scott Frazer, Jessica Frick, Stacey Gabriel, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, Manaswi Gupta, David Haussler, D. Neil Hayes, David I. Heiman, Julian Hess, Katherine A. Hoadley, Robert Hoffmann, Robert A. Holt, Alan P. Hoyle, Xin Hu, Mei Huang, Carolyn M. Hutter, Stuart R. Jefferys, Steven J.M. Jones, Corbin D. Jones, Rupa S. Kanchi, Cyriac Kandoth, Katayoon Kasaian, Sarah Kerr, Jaegil Kim, Phillip H. Lai, Peter W. Laird, Eric Lander, Michael S. Lawrence, Darlene Lee, Kristen M. Leraas, Ignaty Leshchiner, Douglas A. Levine, Tara M. Lichtenberg, Pei Lin, Shiyun Ling, Jia Liu, Wenbin Liu, Yuexin Liu, Laxmi Lolla, Yiling Lu, Yussanne Ma, Dennis T. Maglinte, Marco A. Marra, Michael Mayo, Shaowu Meng, Matthew Meyerson, Piotr A. Mieczkowski, Gordon B. Mills, Richard A. Moore, Lisle E. Mose, Andrew J. Mungall, Karen Mungall, Bradley A. Murray, Rashi Naresh, Michael S. Noble, Narciso Olvera, Joel S. Parker, Charles M. Perou, Amy H. Perou, Todd Pihl, Amie J. Radenbaugh, Nilsa C. Ramirez, W. Kimryn Rathmell, Jeffrey Roach, A. Gordon Robertson, Sara Sadeghi, Gordon Saksena, Helga B. Salvesen, Jacqueline E. Schein, Steven E. Schumacher, Hui Shen, Margi Sheth, Yan Shi, Juliann Shih, Janae V. Simons, Payal Sipahimalani, Tara Skelly, Heidi J. Sofia, Matthew G. Soloway, Robert A. Soslow, Carrie Sougnez, Chip Stewart, Charlie Sun, Angela Tam, Donghui Tan, Roy Tarnuzzer, Nina Thiessen, Leigh B. Thorne, Kane Tse, Jill Tseng, David J. Van Den Berg, Umadevi Veluvolu, Roel G.W. Verhaak, Doug Voet, Amanda von Bismarck, Vonn Walter, Yunhu Wan, Zhining Wang, Chen Wang, John N. Weinstein, Daniel J. Weisenberger, Matthew D. Wilkerson, Boris Winterhoff, Lisa Wise, Tina Wong, Ye Wu, Liming Yang, Jean C. Zenklusen, Jiashan (Julia) Zhang, Hailei Zhang, Wei Zhang, Jing-chun Zhu, Erik Zmuda & Rosemary E. Zuna. (2017) Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell 31:3, pages 411-423.
Crossref
Crossref
Ayse Ayhan, Elisabetta Kuhn, Ren-Chin Wu, Hiroshi Ogawa, Asli Bahadirli-Talbott, Tsui-Lien Mao, Haruhiko Sugimura, Ie-Ming Shih & Tian-Li Wang. (2017) CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis. Modern Pathology 30:2, pages 297-303.
Crossref
Crossref
Roodolph St. Pierre & Cigall Kadoch. (2017) Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities. Current Opinion in Genetics & Development 42, pages 56-67.
Crossref
Crossref
Lisa Maria Mustachio, Masanori Kawakami, Yun Lu, Jaime Rodriguez-Canales, Barbara Mino, Carmen Behrens, Ignacio Wistuba, Neus Bota-Rabassedas, Jun Yu, J. Jack Lee, Jason Roszik, Lin Zheng, Xi Liu, Sarah J. Freemantle & Ethan Dmitrovsky. (2016) The ISG15-specific protease USP18 regulates stability of PTEN. Oncotarget 8:1, pages 3-14.
Crossref
Crossref
Mateusz Bujko, Marcin M. Machnicki, Emilia Grecka, Nataliia Rusetska, Ewa Matyja, Paulina Kober, Tomasz Mandat, Małgorzata Rydzanicz, Rafał Płoski, Romuald Krajewski, Wieslaw Bonicki, Tomasz Stokłosa & Janusz A. Siedlecki. (2017) Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype. World Neurosurgery 97, pages 754.e1-754.e6.
Crossref
Crossref
Katherine C. Kurnit, Bojana Djordjevic & Russell R. Broaddus. 2017. Precision Molecular Pathology of Uterine Cancer. Precision Molecular Pathology of Uterine Cancer
65
86
.
Zhihui Liu & Carol J. Thiele. 2017. Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors. Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors
83
125
.
Daniel H. Ahn, Milind Javle, Chul W. Ahn, Apurva Jain, Sameh Mikhail, Anne M. Noonan, Christina Wu, Rachna T. Shroff, James L. Chen & Tanios Bekaii-Saab. (2016) Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance. Cancer 122:23, pages 3657-3666.
Crossref
Crossref
Martin H. VossAna M. MolinaYing-Bei ChenKaitlin M. WooJoshua L. ChaimDevyn T. CoskeyAlmedina RedzematovicPatricia WangWilliam LeeS. Duygu SelcukluChung-Han LeeMichael F. BergerSatish K. TickooVictor E. ReuterSujata PatilJames J. HsiehRobert J. MotzerDarren R. Feldman. (2016) Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non–Clear Cell Renal Cell Carcinoma. Journal of Clinical Oncology 34:32, pages 3846-3853.
Crossref
Crossref
Davendra P.S. Sohal, Shiva Shrotriya, Mohamed Abazeed, Michael Cruise & Alok Khorana. (2016) Molecular characteristics of biliary tract cancer. Critical Reviews in Oncology/Hematology 107, pages 111-118.
Crossref
Crossref
Apurva Jain, Lawrence N Kwong & Milind Javle. (2016) Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice. Current Treatment Options in Oncology 17:11.
Crossref
Crossref
Marta Jessica Llorca-Cardeñosa, Tania Fleitas, Maider Ibarrola-Villava, María Peña-Chilet, Cristina Mongort, Carolina Martinez-Ciarpaglini, Lara Navarro, Valentina Gambardella, Josefa Castillo, Susana Roselló, Samuel Navarro, Gloria Ribas & Andrés Cervantes. (2016) Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment. Oncotarget 7:39, pages 63424-63436.
Crossref
Crossref
Wen-Cheng Lu, Chung-Ji Liu, Hsi-Feng Tu, Yu-Tung Chung, Cheng-Chieh Yang, Shou-Yen Kao, Kuo-Wei Chang & Shu-Chun Lin. (2016)
miR-31
targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma
. Oncotarget 7:35, pages 57254-57267.
Crossref
Crossref
Nithya Kartha, Lishuang Shen, Carolyn Maskin, Marsha Wallace & John C Schimenti. (2016)
The Chromatin Remodeling Component
Arid1a
Is a Suppressor of Spontaneous Mammary Tumors in Mice
. Genetics 203:4, pages 1601-1611.
Crossref
Crossref
Ruibin Xi, Semin Lee, Yuchao Xia, Tae-Min Kim & Peter J. Park. (2016) Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants. Nucleic Acids Research 44:13, pages 6274-6286.
Crossref
Crossref
Yujie Duan, Ling Tian, Qingzhu Gao, Li Liang, Wenlu Zhang, Yi Yang, Yaqiu Zheng, E Pan, Shengwei Li & Ni Tang. (2016)
Chromatin remodeling gene
ARID2
targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression
. Oncotarget 7:29, pages 45863-45875.
Crossref
Crossref
David Reisman, Kenneth Thompson, Stefanie Marquez‐Vilendrer & Li Lu. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
19
.
Balabhadrapatruni V.S.K. Chakravarthi, Saroj Nepal & Sooryanarayana Varambally. (2016) Genomic and Epigenomic Alterations in Cancer. The American Journal of Pathology 186:7, pages 1724-1735.
Crossref
Crossref
Lin Yang, Sheng Wei, Rongxian Zhao, Yingxing Wu, Hong Qiu & Huihua Xiong. (2016) Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies. Scientific Reports 6:1.
Crossref
Crossref
John P. Stamp, C. Blake Gilks, Martine Wesseling, Sima Eshragh, Kathy Ceballos, Michael S. Anglesio, Janice S. Kwon, Alicia Tone, David G. Huntsman & Mark S. Carey. (2016) BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer. International Journal of Gynecological Cancer 26:5, pages 825-832.
Crossref
Crossref
Yohan Suryo Rahmanto, Jin-Gyoung Jung, Ren-Chin Wu, Yusuke Kobayashi, Christopher M. Heaphy, Alan K. Meeker, Tian-Li Wang & Ie-Ming Shih. (2016) Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells. Journal of Biological Chemistry 291:18, pages 9690-9699.
Crossref
Crossref
Seungkyu ChoiJai Hyang GoEun Kyung KimHojung LeeWon Mi LeeChun-Sung ChoKyudong Han. (2016) Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel. Genomics & Informatics 14:3, pages 78.
Crossref
Crossref
Zhao-Shan Niu, Xiao-Jun Niu & Wen-Hong Wang. (2016) Genetic alterations in hepatocellular carcinoma: An update. World Journal of Gastroenterology 22:41, pages 9069.
Crossref
Crossref
Byungho Lim. (2016) Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer. World Journal of Gastroenterology 22:3, pages 1190.
Crossref
Crossref
Maristella Saponara, Milena Urbini, Annalisa Astolfi, Valentina Indio, Giorgio Ercolani, Massimo Del Gaudio, Donatella Santini, Maria Giulia Pirini, Michelangelo Fiorentino, Margherita Nannini, Cristian Lolli, Anna Mandrioli, Lidia Gatto, Giovanni Brandi, Guido Biasco, Antonio Daniele Pinna & Maria Abbondanza Pantaleo. (2015) Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS). Oncotarget 6:39, pages 42243-42257.
Crossref
Crossref
Fei He, Jie Li, JianFeng Xu, Sheng Zhang, YaPing Xu, WenXiu Zhao, ZhenYu Yin & XiaoMin Wang. (2015) Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
Cyril Dalmasso, Wassila Carpentier, Catherine Guettier, Sophie Camilleri-Broët, Wyllians Vendramini Borelli, Cedália Rosane Campos dos Santos, Denis Castaing, Jean-Charles Duclos-Vallée & Philippe Broët. (2015) Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma. BMC Cancer 15:1.
Crossref
Crossref
Kyoko Nishikimi, Takako Kiyokawa, Shinichi Tate, Masami Iwamoto & Makio Shozu. (2015)
ARID1A
expression in ovarian clear cell carcinoma with an adenofibromatous component
. Histopathology 67:6, pages 866-871.
Crossref
Crossref
Claudio Luchini, Nicola Veronese, Marco Solmi, Hanbyoul Cho, Jae-Hoon Kim, Angela Chou, Anthony J. Gill, Sheila F. Faraj, Alcides Chaux, George J. Netto, Kentaro Nakayama, Satoru Kyo, Soo Young Lee, Duck-Woo Kim, George M. Yousef, Andreas Scorilas, Gregg S. Nelson, Martin Köbel, Steve E. Kalloger, David F. Schaeffer, Hai-Bo Yan, Feng Liu, Yoshihito Yokoyama, Xianyu Zhang, Da Pang, Zsuzsanna Lichner, Giuseppe Sergi, Enzo Manzato, Paola Capelli, Laura D. Wood, Aldo Scarpa & Christoph U. Correll. (2015) Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. Oncotarget 6:36, pages 39088-39097.
Crossref
Crossref
M A Lunning & M R Green. (2015) Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas. Blood Cancer Journal 5:10, pages e361-e361.
Crossref
Crossref
Keyvan Torabi, Rosa Miró, Nora Fernández-Jiménez, Isabel Quintanilla, Laia Ramos, Esther Prat, Javier del Rey, Núria Pujol, J. Keith Killian, Paul S. Meltzer, Pedro Luis Fernández, Thomas Ried, Juan José Lozano, Jordi Camps & Immaculada Ponsa. (2015) Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer. Carcinogenesis 36:10, pages 1103-1110.
Crossref
Crossref
Mark J. Kiel, Anagh A. Sahasrabuddhe, Delphine C. M. Rolland, Thirunavukkarasu Velusamy, Fuzon Chung, Matthew Schaller, Nathanael G. Bailey, Bryan L. Betz, Roberto N. Miranda, Pierluigi Porcu, John C. Byrd, L. Jeffrey Medeiros, Steven L. Kunkel, David W. Bahler, Megan S. Lim & Kojo S. J. Elenitoba-Johnson. (2015) Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome. Nature Communications 6:1.
Crossref
Crossref
Jianfeng Shen, Yang Peng, Leizhen Wei, Wei Zhang, Lin Yang, Li Lan, Prabodh Kapoor, Zhenlin Ju, Qianxing Mo, Ie-Ming Shih, Ivan P. Uray, Xiangwei Wu, Powel H. Brown, Xuetong Shen, Gordon B. Mills & Guang Peng. (2015) ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors. Cancer Discovery 5:7, pages 752-767.
Crossref
Crossref
Ayse Ayhan, Tsui‐Lien Mao, Yohan Suryo Rahmanto, Felix Zeppernick, Hiroshi Ogawa, Ren‐Chin Wu, Tian‐Li Wang & Ie‐Ming Shih. (2015) Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors. The Journal of Pathology: Clinical Research 1:3, pages 186-193.
Crossref
Crossref
Lauren Patterson Cobb, Stephanie Gaillard, Yihong Wang, Ie-Ming Shih & Angeles Alvarez Secord. (2015) Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms. Gynecologic Oncology Research and Practice 2:1.
Crossref
Crossref
G. Niegisch, M.J. Hoffmann, E.A. Koutsogiannouli & W.A. Schulz. (2015) Epigenetik des UrothelkarzinomsEpigenetics in urothelial cancer. Der Urologe 54:4, pages 526-532.
Crossref
Crossref
Hye Rim Oh, Chang Hyeok An, Nam Jin Yoo & Sug Hyung Lee. (2015) Frameshift mutations of TAF1C gene, a core component for transcription by RNA polymerase I, and its regional heterogeneity in gastric and colorectal cancers. Pathology 47:2, pages 101-104.
Crossref
Crossref
Kyung-Ju KimHae Yoen JungMee-Hye OhHyundeuk ChoJi-Hye LeeHyun Ju LeeSi-Hyong JangMoon Soo Lee. (2015) Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features. Journal of Gastric Cancer 15:3, pages 201.
Crossref
Crossref
Min Jin HaVeerabhadran BaladandayuthapaniKim-Anh Do. (2015) Prognostic Gene Signature Identification Using Causal Structure Learning: Applications in Kidney Cancer. Cancer Informatics 14s1, pages CIN.S14873.
Crossref
Crossref
Yohei Ozawa, Yasuhiro Nakamura, Fumiyoshi Fujishima, Saulo J.A. Felizola, Kenichiro Takeda, Hiroshi Okamoto, Ken Ito, Hirotaka Ishida, Takuro Konno, Takashi Kamei, Noriaki Ohuchi & Hironobu Sasano. (2015) Decreased Expression of ARID1A Contributes to Infiltrative Growth of Esophageal Squamous Cell Carcinoma. The Tohoku Journal of Experimental Medicine 235:3, pages 185-191.
Crossref
Crossref
J. Michael Randall, Frederick Millard & Razelle Kurzrock. (2014) Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art. Cancer and Metastasis Reviews 33:4, pages 1109-1124.
Crossref
Crossref
Guang-Xiao Meng, Chun-Cheng Yang, Lun-Jie Yan, Ya-Fei Yang, Yu-Chuang Yan, Jian-Guo Hong, Zhi-Qiang Chen, Zhao-Ru Dong & Tao Li. (2022) The Somatic Mutational Landscape and Role of ARID1A Gene in Hepatocellular Carcinoma. SSRN Electronic Journal.
Crossref
Crossref
Jaime Iranzo, George Gruenhagen, Jorge Calle-Espinosa & Eugene Koonin. (2022) Pervasive Conditional Selection of Driver Mutations and Modular Epistasis Networks in Cancer. SSRN Electronic Journal.
Crossref
Crossref